DE2967257D1 - Composition for regulating dopamine or norepinephrine levels in neuronal synapses - Google Patents
Composition for regulating dopamine or norepinephrine levels in neuronal synapsesInfo
- Publication number
- DE2967257D1 DE2967257D1 DE7979300650T DE2967257T DE2967257D1 DE 2967257 D1 DE2967257 D1 DE 2967257D1 DE 7979300650 T DE7979300650 T DE 7979300650T DE 2967257 T DE2967257 T DE 2967257T DE 2967257 D1 DE2967257 D1 DE 2967257D1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- norepinephrine levels
- neuronal synapses
- regulating dopamine
- dopamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89874078A | 1978-04-24 | 1978-04-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2967257D1 true DE2967257D1 (en) | 1984-11-22 |
Family
ID=25409977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE7979300650T Expired DE2967257D1 (en) | 1978-04-24 | 1979-04-20 | Composition for regulating dopamine or norepinephrine levels in neuronal synapses |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0005058B1 (de) |
JP (2) | JPS557261A (de) |
CA (1) | CA1140859A (de) |
DE (1) | DE2967257D1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0083338B1 (de) * | 1981-07-15 | 1987-10-14 | WURTMAN, Richard J. | Zusammensetzung zur erhöhung des blutdrucks |
US4542123A (en) * | 1982-01-11 | 1985-09-17 | Massachusetts Institute Of Technology | Composition and method for increasing brain tyrosine levels |
DE3479477D1 (en) * | 1983-05-16 | 1989-09-28 | Massachusetts Inst Technology | A pharmaceutical composition for use in treating neurological disease or aging |
JP2601865Y2 (ja) * | 1993-03-04 | 1999-12-06 | 日産ディーゼル工業株式会社 | 電動ミラーアームの支持装置 |
US5480865A (en) * | 1994-02-25 | 1996-01-02 | Parkinson's Charitable Trust | Nutritional composition |
JP2004123564A (ja) * | 2002-09-30 | 2004-04-22 | Inst Of Physical & Chemical Res | 中枢機能改善用アミノ酸組成物 |
CN112924598B (zh) * | 2021-01-28 | 2023-07-28 | 广州市妇女儿童医疗中心 | 生物胺类神经递质的定量分析方法 |
CN117919232A (zh) * | 2023-11-30 | 2024-04-26 | 上海市东方医院(同济大学附属东方医院) | 吲哚丙酸在治疗自身免疫性肝损伤和肝硬化中的应用 |
-
1979
- 1979-04-20 EP EP79300650A patent/EP0005058B1/de not_active Expired
- 1979-04-20 DE DE7979300650T patent/DE2967257D1/de not_active Expired
- 1979-04-24 JP JP4983279A patent/JPS557261A/ja active Granted
- 1979-04-24 CA CA000326257A patent/CA1140859A/en not_active Expired
- 1979-04-24 JP JP4983079A patent/JPS54145219A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
EP0005058A2 (de) | 1979-10-31 |
JPS557261A (en) | 1980-01-19 |
JPS6326086B2 (de) | 1988-05-27 |
JPS54145219A (en) | 1979-11-13 |
JPS647044B2 (de) | 1989-02-07 |
CA1140859A (en) | 1983-02-08 |
EP0005058B1 (de) | 1984-10-17 |
EP0005058A3 (en) | 1979-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3165711D1 (en) | Apparatus for depilating with wax, in particular for the face | |
GB1555796A (en) | Composition for treating acne | |
JPS559677A (en) | Cross linked polymer composition | |
JPS5592762A (en) | Wax composition | |
GB2102918B (en) | Relief valve | |
JPS5799525A (en) | Acne local treatment composition | |
GB2025444B (en) | Coating composition | |
DE2967257D1 (en) | Composition for regulating dopamine or norepinephrine levels in neuronal synapses | |
JPS5565551A (en) | Film composition | |
JPS54125191A (en) | Spill control composition and use thereof | |
GB2029221B (en) | Compositions comprising l-dopa for treating parkinsoisms | |
GB2035514B (en) | Adjustable relief valve | |
JPS54145234A (en) | Sterilizing composition | |
JPS54140714A (en) | Skin treating composition | |
JPS5555117A (en) | Medicine for treating bladder in tension excess state | |
JPS57163311A (en) | Psoriasis treating composition | |
GB2025983B (en) | Coating composition for imparting scuff resistance | |
DE3175269D1 (en) | Composition for activating hair grooth | |
BG31641A3 (en) | Herbicide composition | |
JPS54132233A (en) | Fungicide composition | |
JPS5762050A (en) | Novel container for photographic treatment composition | |
JPS5792557A (en) | Undercoating treating composition | |
JPS5322538A (en) | Ultraviolet hardenable coating composition | |
JPS5761651A (en) | Under treatment composition | |
JPS5526928A (en) | Beauty physical training tool |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |